Historically, Real World Evidence (RWE) has been retained as a lifecycle management tool to be used at the end of clinical development. Today, we’re facing a more competitive pricing and outcomes-based environment.
Halloween Lunch and Learn | Tricks & Treats: Insights for Holistic Evidence Planning During Clinical Development
Scary, indeed! Never fear, because generating holistic evidence alongside clinical development can help raise the likelihood for optimised pricing, faster reimbursement and earlier revenues. This not only improves return on investment (ROI) but also provides optionality as companies become more attractive for partnering, should that be part of their strategy.
Syneos Health speakers, Noolie Gregory, Executive Director, Client Engagement, Real World Evidence, and Martin Gouldstone, Senior Vice President, Syneos One, will treat you to insights on using RWE to drive successful clinical development and commercialization.
Please note, you will be informed if your registration has been unsuccessful within 2 working days of registering online for the event.
12.00 - Guests Arrive
12.15 - Welcome from the Hosts/Lunch Start
12.30 - Presentations
Noolie Gregory, Executive Director, Client Engagement, Real World Evidence, Syneos Health
Martin Gouldstone, Senior Vice President, Syneos One and Head of Capital Solutions
13.30 – Close
One Nucleus is a membership organisation for international life science and healthcare companies. We are based in Cambridge and London UK, the heart of Europe’s largest life science and healthcare cluster.